http://nutritionthoughts.blogspot.com

Monday, November 17, 2008

vitamin D dosage for the young

The American Academy of Pediatrics has recommended doubling its recommended dose of vitmin D for infants, children and adolescents to 400 IU daily. Clinical trials show that this dosage gives protection against rickets , boots immunity and reduces osteoporosis in later life.

Labels: ,

Monday, November 03, 2008

caffeine and anxiety

There is no limit to how far molecular biology is extending to explain biological phenomenon. This is a brilliant example of hw such studies can explain. Some people are very susceptible to caffeine and become anxious. Others aren’t. This paper explains a possible reason.
Association between ADORA2A and DRD2 Polymorphisms and Caffeine-Induced Anxiety
Caffeine produces mild psychostimulant and sometimes anxiogenic effects by antagonizing adenosine at A1 and A2A receptors, and perhaps through interactions with other transmitter systems. Adenosine receptors are colocalized and functionally interact with dopamine receptors in the brain. Thus, functional polymorphisms in the genes for either adenosine or dopamine receptors may affect responses to caffeine. In this study, we examined associations between self-reported anxiogenic effects of caffeine and variation in the genes for A2A (ADORA2A) and DRD2 (DRD2) receptors. Healthy male and female individuals (n=102), who consumed less than 300 mg caffeine per week, ingested capsules containing 0, 50, 150, and 450 mg caffeine under double-blind conditions in four separate experimental sessions. Subjective anxiety was measured before and at repeated times after capsules were consumed. At the 150 mg dose of caffeine, we found a significant association between caffeine-induced anxiety (Visual Analog Scales, VAS) and ADORA2A rs5751876 (1976C/T), rs2298383 (intron 1a) and rs4822492 (3'-flank), and DRD2 rs1110976 (intron 6). Caffeine-induced anxiety (VAS) was also associated with two-loci interactions of selected ADORA2A and DRD2 polymorphisms. The lowest dose of caffeine did not increase ratings of anxiety while the highest dose increased anxiety in the majority of subjects. These findings provide support for an association between an ADORA2A polymorphism and self-reported anxiety after a moderate dose of caffeine. It is likely that other ADORA2A and DRD2 polymorphisms also contribute to responses to caffeine.
Childs,Hohoff, Deckert, Ke Xu, Badner and de Wit ( 2008) Association between ADORA2A and DRD2 Polymorphisms and Caffeine-Induced Anxiety. Neuropsychopharmacology (2008) 33, 2791–2800; 27 February 2008

Labels: ,

anti-ageing genes and cancer

This is an interesting Perspective on turning anti-ageing genes against cancer. In such fluid states nutrition is bound to have a role.
Recent studies in diverse organisms implicate proto-oncogenic pathways, including insulin-like growth factor-I (IGF-I), Ras and AKT/protein kinase B in the ageing process. Although IGF-I is thought to contribute to cancer by promoting growth and preventing apoptosis, evidence from model organisms suggests that proto-oncogene homologues might contribute to the DNA mutations and chromosomal damage that are observed in tumour cells by increasing DNA damage, in both dividing and non-dividing cells, and involving error-prone systems in DNA repair. This raises the possibility that cancer can be reduced by chronic down regulation of pro-ageing pathways.
Longo, Lieber & Vijg ( 2008 ) Perspective on turning anti-ageing genes against cancer. Nature Reviews Molecular Cell Biology 9, 903-910 (November 2008)

Labels: ,

metabolic syndrome biology review

This is an interesting Review of the Metabolic syndrome: from epidemiology to systems biology
The Metabolic syndrome is a group of metabolic conditions that occur together and promote the development of cardiovascular disease and diabetes. Recent genome-wide association studies have identified several novel susceptibility genes for Metabolic syndrome traits, and studies in rodent models have provided important molecular insights. However, as yet, only a small fraction of the genetic component is known. Systems-based approaches that integrate genomic, molecular and physiological data are complementing traditional genetic and biochemical approaches to more fully address the complexity of Metabolic syndrome.
Lusis, Attie & Reue 2008 Metabolic syndrome: from epidemiology to systems biology Nature Reviews Genetics 9, 819-830 (November 2008) |

Labels:

age and cancer

It is so easy to be simplistic about the aetiology of cancer. This review is of great interest in this respect. Read the full article and be cautious in future.
Two paradigms central to geroscience research are that aging is associated with increased oxidative stress and increased cancer risk. Therefore, it could be deduced that cancers arising with ageing will show evidence of increased oxidative stress. Recent studies of gene expression in age-controlled breast cancer cases indicate that this deduction is false, posing parallax views of these two paradigms, and highlighting the unanswered question: does ageing cause or simply permit cancer development?
Benz1 & Yau (November 2008) Ageing, oxidative stress and cancer: paradigms in parallax Nature Reviews Cancer 8, 875-879

Labels: , ,

Genes and cancer

Hi:
My friend Charlie Bonfield sends interesting notes to his friends. Here is a very interesting one.
An article on the possible connection between cancer and genes unique to humans.
Among the approximately 23,000 genes found in human DNA, scientists currently estimate that there may be as few as 50 to 100 that have no counterparts in other species. Expand that comparison to include the primate family known as hominoids, and there may be several hundred unique genes.
Despite the distinctive contributions these genes likely make to our species, little is known about the roles they play. Now scientists at Washington University School of Medicine in St. Louis have produced the first detailed analysis of the cellular functions of a hominoid-only gene, TBC1D3. They affirmed earlier evidence linking the gene to cancer, showing that TBC1D3's protein can keep cellular growth factors active and helps turn on RAS, a protein that is active in a third of all human cancers.
"I was astounded at how little attention has been given to human-specific genes, which make us what we are and could potentially offer a great deal of insight into human physiology," says senior author Philip D. Stahl, Ph.D., the Edward Mallinckrodt Jr. Professor and head of Cell Biology and Physiology. "In addition, certain pathogens, such as the malaria parasite, have human specific-components in their infection cycle. Human-only genes could offer us unique insights into how the parasites take advantage of us and possibly provide potent new avenues for fighting back."
The paper appears online in The Journal of Biological Chemistry.
When scientists want to learn more about the function of a gene, they frequently disable or delete the gene in a laboratory animal and then look to see how the loss changes the animal. That won't be possible with genes unique to humans, Stahl notes. Researchers will have to resort to altering the genes' functions in human cell lines, or transplanting them into animals to see what effects they have.
TBC1D3 was originally identified by other scientists as a likely contributor to breast cancer. At the time of its discovery, researchers linked its protein to endocytosis, a process cells use to take in material from their surface. Endocytosis plays an important role in the Stahl laboratory. His group studies how growth factor receptors, proteins important for both normal and cancerous growth, are turned on and off. Found on the surfaces of cells, growth factor receptors turn on when they bind to a growth factor protein. To turn them off, cells take in the combined receptor-protein through endocytosis and put it through a number of different processes before finally breaking down the growth factor receptor. When Stahl and colleagues determined in 2006 that the TBC1D3 gene is only found in hominoids, their curiosity was piqued. Evolution, Stahl notes, naturally tends to retain genes involved in the most important components of metabolism. If one of these genes mutated too dramatically, that would lead to an organism so sickly that it wouldn't survive long enough to perpetuate the mutation in its descendants. So evolution "conserves" these genes, retaining them largely unchanged as one species evolves into another.
Therefore, if the genome is compared to an automobile, human-only genes are unlikely to be adding new wheels. But they could, for example, be contributing a new anti-lock braking system: a regulatory function that fine-tunes essential processes originally established millennia ago in other species.
Stahl found evidence that this is the case in TBC1D3. Human DNA has eight copies or paralogs of the TBC1D3 gene. His lab showed that the increased levels of the protein made by one of the paralogs makes human cells grow more rapidly. When they transplanted the gene for the protein into mouse cells, it had the same effect.
A closer look showed that the protein from the TBC1D3 paralog delays a process that labels growth factor receptors for breakdown, prolonging the time that their signal is active.
He also found evidence that the protein was helping to activate RAS, another gene whose protein is commonly found in human cancers.
Stahl and his colleagues plan additional research to learn whether the other paralogs of TBC1D3 have different roles. He also has several ideas for learning more about the functions of human-only genes.
"We might try an organ-by-organ approach, looking to see if any genes specific to a particular organs, such as fat, are specific to humans," he says. "We also should probably look at crystallizing the proteins from some of these genes, which can tell us more about what they interact with."
There may be human diseases where these genes are mutated or missing, Stahl speculates. The effects of such conditions could provide important clues to what the humans-only genes do.
"It's also going to be very interesting for evolutionary biologists to try to develop a sense for where these humans-only genes come from," Stahl says. "The building blocks of these genes may be present but not active in earlier species."
###
Wainszelbaum MJ, Charron AJ, Kong C, Kirkpatrick DS, Srikanth P, Barbieri MA, Gygi SP, Stahl PD. The hominoid-specific oncogene TBC1D3 activates RAS and modulates EGF receptor signaling and trafficking. Journal of Biological Chemistry, online publication.

Labels: ,